A versatile approach to pyrrolidine azasugars and homoazasugars based on a highly diastereoselective reductive benzyloxymethylation of protected tartarimide

Tetrahedron

Volumn 63, Issue 27, 2007, Pages 6346-6357

  Zhou, Xiang ^a   Liu, Wen Jun ^a   Ye, Jian Liang ^a   Huang, Pei Qiang ^a  

^a Key Laboratory for Chemical Biology of Fujian Province   (China)

Author keywords

6 Deoxy DMDP; Alkaloids; Azasugars; DAB 1; Diastereoselective synthesis; epi Radicamine B; Hydroxymethylation; LAB 1; Pyrrolidine

Indexed keywords

1,4 DIDEOXY 1,4 IMINO DEXTRO ARABINITOL; 2 (HYDROXYMETHYL) 5 (4 HYDROXYPHENYL)PYRROLIDINE 3,4 DIOL; 3,4 DIHYDROXY 1 HYDROXYETHYL 2 HYDROXYMETHYLPYRROLIDINE; 4 AMINO 2,3,5 TRIHYDROXYPENTYL PHENOL; 5 BENZYLOXYMETHYL 3,4 DIBENZYLOXYL 1 (4 METHOXYBENZYL)PYRROLIDIN 2 ONE; ARABINITOL; CARBOHYDRATE DERIVATIVE; IMIDE; PYRROLIDINE DERIVATIVE; SAMARIUM DIIODIDE; UNCLASSIFIED DRUG;

ARTICLE; DRUG SYNTHESIS; METHYLATION; PRIORITY JOURNAL; RING OPENING; STEREOCHEMISTRY;

EID: 34249110615     PISSN: 00404020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tet.2007.02.087     Document Type: Article

References (163)

1. For excellent reviews on the natural occurrence and therapeutic applications of azasugars, see:
2. Look G.C., Fotsch C.H., and Wong C.H. Acc. Chem. Res. 26 (1993) 182-190
3. Ganem B. Acc. Chem. Res. 29 (1996) 340-347
4. Watson A.A., Fleet G.W.J., Asano N., Molyneux R.J., and Nash R.J. Phytochemistry 56 (2001) 265-295
5. Wroding T.M. Monatsh. Chem. 133 (2002) 393-426
6. Asano N., Nash R.J., Molyneux R.J., and Fleet G.W.J. Tetrahedron: Asymmetry 11 (2005) 1645-1680
7. Legler G. In: Stütz A.E. (Ed). Iminosugars as Glycosidase Inhibitors (1998), Wiley-VCH, New York, NY Chapter 3
8. Horii S., Fukase H., Matsuo T., Kameda Y., Asano N., and Matsui K. J. Med. Chem. 29 (1986) 1038-1046
9. Fischer P.B., Collin M., Karlsson G.B., James M., Butters T.D., Davis S.J., Gordon S., Dwek R.A., and Platt F.M. J. Virol. 69 (1995) 5791-5797
10. Furukawa J., Okuda S., Saito K., and Hatanaka S.-I. Phytochemistry 24 (1985) 593-594
11. Nash R.J., Bell E.A., and Williams J.M. Phytochemistry 24 (1985) 1620-1622
12. Jones D.W.C., Nash R.J., Bell E.A., and Williams J.M. Tetrahedron Lett. 26 (1985) 3125-3126
13. Fleet G.W.J., Nicholas S.J., Smith P.W., Evans S.V., Fellows L.E., and Nash R.J. Tetrahedron Lett. 26 (1985) 3127-3130
14. Scofield A.M., Fellows L.E., Nash R.J., and Fleet G.W. Life Sci. 39 (1986) 645-650
15. Axamawaty M.T.H., Fleet G.W.J., Hannah K.A., Namgoong S.K., and Sinnott M.L. Biochem. J. 266 (1990) 245-249
16. Mackay P., Ynddal L., Andersen J.V., and McCormack J.G. Diabetes Obes. Metab. 5 (2003) 397-407
17. Fleet G.W.J., Karpas A., Dwek R.A., Fellows L.E., Tyms A.S., Petursson S., Namgoong S.K., Ramsden N.G., Jacob G.S., and Rademacher T.W. FEBS Lett. 237 (1988) 128-132
18. Karpas A., Fleet G.W.J., Dwek R.A., Petursson S., Namgoong S.K., Ramsden N.G., Jacob G.S., and Rademacher T.W. Proc. Natl. Acad. Sci. U.S.A. 85 (1988) 9229-9233
19. Shibata T., Nakayama O., Tsurumi Y., Okuhara M., Terno H., and Kohsaka M. J. Antibiot. 41 (1988) 296-301
20. Kayakiri H., Yakase S., Setoi H., Uchida I., Terano H., and Hashimoto M. Tetrahedron Lett. 29 (1988) 1725-1728
21. Ysujii E., Muroi M., Shiragami N., and Takatsuki A. Biochem. Biophys. Res. Commun. 220 (1996) 459-466
22. Yasuda K., Kizu H., Yamashita T., Kameda Y., Kato A., Nash R.J., Fleet G.W.J., Molyneux R.J., and Asano N. J. Nat. Prod. 65 (2002) 198-202
23. Buku A., Faulstich H., Wieland T., and Dabrowski J. Proc. Natl. Acad. Sci. U.S.A. 77 (1980) 2370-2371
24. Faulstich H., Buku A., Bodenmueller H., and Wieland T. Biochemistry 19 (1980) 3334-3343
25. Dondoni A., Giovannini P.P., and Perrone D. J. Org. Chem. 67 (2002) 7203-7214
26. Welter A., Jadot J., Dardenne G., Marlier M., and Casimir J. Phytochemistry 15 (1976) 747-749
27. Nash R.J., Asano N., and Eatson A.A. In: Pelletier S.W. (Ed). Alkaloids: Chemical and Biological Perspectives Vol. 11 (1996), Elsevier Science, Oxford 345-376
28. Molyneux R.J., Pan Y.T., Tropea J.E., Elbein A.D., Lawyer C.H., Hughes D.J., and Fleet G.W.J. J. Nat. Prod. 56 (1993) 1356-1364
29. Asano N., Yasuda K., Kizu H., Kato A., Fan J.-Q., Nash R.J., Fleet G.W.J., and Molyneux R.J. Eur. J. Biochem. 268 (2001) 35-41
30. Shibano M., Tsukamoto D., Masuda A., Tanaka Y., and Kusano G. Chem. Pharm. Bull. 49 (2001) 1362-1365
31. Tsukamoto D., Shibano M., and Kusano G. Chem. Pharm. Bull. 49 (2001) 1487-1491
32. For revision of absolute configuration of radicamines, see:
33. Yu C.Y., and Huang M.H. Org. Lett. 8 (2006) 3021-3024
34. For reviews on the enantiomeric synthesis of 2-hydroxymethylpyrrolidine alkaloids, see:
35. Ref. 1c;
36. El-Ashry E.-S.H., and El Nemr A. Carbohydr. Res. 338 (2003) 2265-2290
37. Ayad T., Genisson Y., and Baltas M. Curr. Org. Chem. 8 (2004) 1211-1233
38. For some enantiospecific synthesis of DAB 1 (1), see:
39. Fleet G.W.J., and Smith P.W. Tetrahedron 42 (1986) 5685-5692
40. Ziegler T., Straub A., and Effenberger F. Angew. Chem., Int. Ed. Engl. 27 (1988) 716-717
41. von der Osten C.H., Sinskey A.J., Barbas III C.F., Pederson R.L., Wang Y.F., and Wong C.H. J. Am. Chem. Soc. 111 (1989) 3924-3927
42. Fleet G.E.J., and Witty D.R. Tetrahedron: Asymmetry 1 (1990) 119-136
43. Hung R.R., Straub J.A., and Whitesides G.M. J. Org. Chem. 56 (1991) 3849-3855
44. Griffat-Brunet D., and Langlois N. Tetrahedron Lett. 35 (1994) 2889-2890
45. Overkleeft H.S., van Wiltenburg J., and Pandit U.K. Tetrahedron 50 (1994) 4215-4224
46. Huwe C.M., and Blechert S. Synthesis (1997) 61-67
47. Kim Y.J., Kido M., Bando M., and Kitahara T. Tetrahedron 53 (1997) 7501-7508
48. Ahn K.H., and Shin Y.S. Bull. Korean Chem. Soc. 18 (1997) 1192-1194
49. Kim J.H., Yang M.S., Lee W.S., and Park K.H. J. Chem. Soc., Perkin Trans. 1 (1998) 2877-2880
50. Hulme A.N., Montgomery C.H., and Henderson D.K. J. Chem. Soc., Perkin Trans. 1 (2000) 1837-1841
51. Ayad T., Génisson Y., Broussy S., Baltas M., and Gorrichon L. Eur. J. Org. Chem. (2003) 2903-2910
52. Lauritsen A., and Madsen R. Org. Biomol. Chem. 4 (2006) 2898-2905
53. For the enantioselective synthesis of LAB 1 (2), see:
54. Ref. 15a;
55. Behling J.R., Campbell A.L., Babiak K.A., Ng J.S., Medich J., Farid P., and Fleet G.W.J. Tetrahedron 49 (1993) 3359-3366
56. Huang Y., Dalton D.R., and Carroll P.J. J. Org. Chem. 62 (1997) 372-376
57. Ref. 15i;
58. Lombardo M., Fabbroni S., and Trombini C. J. Org. Chem. 66 (2001) 1264-1268
59. For the enantiospecific synthesis of nectrisine (3), see:
60. Chen S.-H., and Danishefsky S.J. Tetrahedron Lett. 31 (1990) 2229-2232
61. Kayakiri H., Nakamura K., Takase S., Setoi H., Uchida I., Terano H., Hashimoto M., Tada T., and Koda S. Chem. Pharm. Bull. 39 (1991) 2807-2812
62. Takayam S., Martin R., Wu J.Y., Laslo K., Siuzdak G., and Wong C.H. J. Am. Chem. Soc. 119 (1997) 8146-8151
63. Kim Y.J., Takatsuki A., Kogoshi N., and Kitahara T. Tetrahedron 55 (1999) 8353-8364
64. Bosco M., Bisseret P., Bouix-Peter C., and Eustache J. Tetrahedron Lett. 42 (2001) 7949-7952
65. Tschamber T., Siendt H., Tarnus C., Deredas D., Frankowski A., Kohler S., and Streith J. Eur. J. Org. Chem. (2002) 702-712
66. Hulme A.N., and Montgomery C.H. Tetrahedron Lett. 44 (2003) 7649-7653
67. For the enantiospecific synthesis of 6-deoxy-DMDP 7, see:
68. Wang Y.-F., Dumas D.P., and Wong C.-H. Tetrahedron Lett. 34 (1993) 403-406
69. Ref. 12a;
70. Bisseret P., Bouix-Peter C., Jacques O., Henriot S., and Eustache J. Org. Lett. 1 (1999) 1181-1182
71. Espelt I., Parella T., Bujons J., Solans C., Joglar J., Delgado A., and Clapes P. Chem.-Eur. J. 9 (2003) 4887-4899
72. Yoda H., Shimojo T., and Takabe K. Tetrahedron Lett. 40 (1999) 1335-1336
73. For some indirect hydroxymethylation methods, see:
74. Barrett A.G.M., and Pilipauskas D. J. Org. Chem. 56 (1991) 2787-2800
75. Kang J., Lee C.W., Lim G.J., and Cho B.T. Tetrahedron: Asymmetry 10 (1999) 657-660
76. Ref. 18;
77. Smith III A.B., Salvatore B.A., Hull K.G., and Duan J.J.W. J. Am. Chem. Soc. 121 (1999) 10468-10477
78. Chen B.F., Tasi M.R., Yang C.Y., Chang J.K., and Chang N.C. Tetrahedron 60 (2004) 10223-10231
79. For two accounts, see:
80. Huang P.-Q. Recent Advances on the Asymmetric Synthesis of Bioactive 2-Pyrrolidinone-related Compounds Starting from Enantiomeric Malic Acid. In: Vicario J.L., Badia D., and Carrillo L. (Eds). New Methods for the Asymmetric Synthesis of Nitrogen Heterocycles (2005), Research Signpost, Kerala 197
81. Huang P.-Q. Synlett (2006) 1133-1149
82. Zheng X., Feng C.-G., Ye J.-L., and Huang P.-Q. Org. Lett. 7 (2005) 553-556
83. Wei B.-G., Chen J., and Huang P.-Q. Tetrahedron 62 (2006) 190-198
84. Zhou X., and Huang P.-Q. Synlett (2006) 1235-1239
85. Zhou, X.; Ye, J.-L.; Huang, P.-Q. C. R. Chim., in press.
86. For reviews on the use of both enantiomers of tartaric acid as chirons, see:
87. Coppola G.M., and Schuster H.F. α-Hydroxy Acids in Enantioselective Syntheses (1997), Wiley-VCH, Weinheim
88. Gawronski J., and Gawronska K. Tartaric and Malic Acids in Synthesis: A Source Book of Building Blocks, Ligands, Auxiliaries, and Resolving Agents (1999), Wiley, New York, NY
89. Ghosh A.K., Koltun E.S., and Bilcer G. Synthesis (2001) 1281-1301
90. For previous reports on the reductive alkylation of O,O′-diTBS-tartarimide, see:
91. Yoda H., Kitayama H., Yamada W., Katagiri T., and Takabe K. Tetrahedron: Asymmetry 4 (1993) 1451-1454
92. Yoda H., Kitayama H., Katagiri T., and Takabe K. Tetrahedron: Asymmetry 4 (1993) 1455-1456
93. Yoda H., Nakajima T., Yamazaki H., and Takabe K. Heterocycles 41 (1995) 2423-2426
94. Yoda H., Nakajima T., and Takabe K. Tetrahedron Lett. 37 (1996) 5531-5534
95. Jeong H.J., Lee J.M., Kim M.K., and Lee S.G. J. Heterocycl. Chem. 39 (2002) 1019-1024
96. For an account, see:
97. Yoda H. Curr. Org. Chem. 6 (2002) 223-243
98. Milosevic P., and Hecht S. Org. Lett. 7 (2005) 5023-5026
99. For some hydroxymethylation methods, see:
100. Still W.C. J. Am. Chem. Soc. 100 (1978) 1481-1487
101. Corey E.J., and Eckrich T.M. Tetrahedron Lett. 24 (1983) 3163-3164
102. Imamoto T., Takeyama M., and Yokoyama M. Tetrahedron Lett. 25 (1984) 3225-3226
103. Sasaki M., Collin J., and Kagan H.B. Tetrahedron Lett. 29 (1988) 4847-4850
104. Nicotra F., Panza L., Ronchetti F., and Russo G. Gazz. Chim. Ital. 119 (1989) 577-579
105. Murakami M., Kawano T., and Ito Y. J. Am. Chem. Soc. 112 (1990) 2437-2439
106. Bols M., and Szarek W.J. J. Chem. Soc., Chem. Commun. (1992) 445-446
107. Kim M., Grzeszczyk B., and Zamojski A. Tetrahedron 56 (2000) 9319-9337
108. Skrydstrup T., Jespersen T., Beau J.M., and Bols M. Chem. Commun. (1996) 515-516
109. For an excellent review, see:
110. Kagan H.B. Tetrahedron 59 (2003) 10351-10372
111. 2 in organic synthesis, see:
112. Huang L.-L., Xu M.-H., and Lin G.-Q. J. Am. Chem. Soc. 128 (2006) 5624-5625
113. Girard P., Namy J.L., and Kagan H.B. J. Am. Chem. Soc. 102 (1980) 2693-2698
114. For a review, see:
115. Kursanov D.N., Parnes Z.N., and Loim N.M. Synthesis (1974) 633-651
116. For selected examples, see:
117. Drage J.S., Earl R.A., and Vollhardt K.P.C. J. Heterocycl. Chem. 19 (1982) 701-702
118. Hart D.J., and Yang T.-K. J. Org. Chem. 50 (1985) 235-242
119. Rolf D., and Gray G.R. J. Am. Chem. Soc. 104 (1982) 3539-3541
120. Thaning M., and Wistrand L.-G. Acta Chem. Scand. 43 (1989) 290-295
121. Thaning M., and Wistrand L.-G. J. Org. Chem. 55 (1990) 1406-1408
122. Jouin P., Castro B., and Nisato D. J. Chem. Soc., Perkin Trans. 1 (1990) 1177-1182
123. Bernardi A., Micheli F., Potenza D., Scolastico C., and Villa R. Tetrahedron Lett. 31 (1990) 4949-4952
124. Koot W.J., Ginkel R.V., Kranenburg M., Hiemstra H., Louwrier S., Moolenaar M.J., and Speckamp W.N. Tetrahedron Lett. 32 (1991) 401-404
125. Huang P.-Q., Wang S.L., Ye J.L., Ruan Y.P., Huang Y.-Q., Zheng H., and Gao J.X. Tetrahedron 54 (1998) 12547-12560
126. Huang P.-Q., Ye J.-L., Chen Z., Ruan R.-P., and Gao J.X. Synth. Commun. 28 (1998) 417-426
127. Oba M., Koguchi S., and Nishiyama K. Tetrahedron 58 (2002) 9359-9363
128. For the situation of 2-oxazolidinone derivatives, see:
129. Rich D.H., Sun E.T.O., and Ulm E. J. Med. Chem. 23 (1980) 27-33
130. He B.-Y., Wu T.-J., Yu X.-Y., and Huang P.-Q. Tetrahedron: Asymmetry 14 (2003) 2101-2108
131. Ye J.-L., Huang P.-Q., and Lu X. J. Org. Chem. 72 (2007) 35-42
132. Yamaura M., Suzuki T., Hashimoto H., Yoshimura J., Okamoto T., and Shin C. Bull. Chem. Soc. Jpn. 58 (1985) 1413-1420
133. Yoshimura J., Yamaura M., Suzuki T., and Hashimoto H. Chem. Lett. (1983) 1001-1002
134. Yoda H., Yamazaki H., and Takabe K. Tetrahedron: Asymmetry 7 (1996) 373-374
135. Kanazawa A., Gillet S., Delair P., and Greene A.E. J. Org. Chem. 63 (1998) 4660-4663
136. Huang P.-Q., Wu T.-J., and Ruan Y.-P. Org. Lett. 5 (2003) 4341-4344
137. For recent reviews on the chemistry of N-acyliminium ions, see:
138. Speckamp W.N., and Moolenaar M.J. Tetrahedron 56 (2000) 3817-3856
139. Bur S.K., and Martin S.F. Tetrahedron 57 (2001) 3221-3242
140. Maryanoff B.E., Zhang H.-C., Cohen J.H., Turchi I.J., and Maryanoff C.A. Chem. Rev. 104 (2004) 1431-1628
141. Royer J. Chem. Rev. 104 (2004) 2311-2352
142. For another asymmetric synthesis of radicamine B (8), see:. Gurjar M.K., Borhade R.G., Puranik V.G., and Ramana C.V. Tetrahedron Lett. 47 (2006) 6979-6981
143. Liu L.-X., Ruan Y.-P., Guo Z.-Q., and Huang P.-Q. J. Org. Chem. 69 (2004) 6001-6009
144. Miles R.W., Tyler P.C., Evans G.B., Furneaux R.H., Parkin D.W., and Schramm V.L. Biochemistry 38 (1999) 13147-13154
145. Severino E.A., Costenaro E.R., Garcia A.L.L., and Correia C.R.D. Org. Lett. 5 (2003) 305-308
146. For a review on the oxidative degradation of benzene rings, see:
147. Mander L.N., and Williams C.M. Tetrahedron 59 (2003) 1105-1136
148. For an example of using oxidative degradation of p-methoxyphenyl group (into a carboxyl group) in the asymmetric synthesis of DMDP, see:
149. Garcia A.L.L., and Correia C.R.D. Tetrahedron Lett. 44 (2003) 1553-1557
150. Smith D.M., and Woerpel K.A. Org. Lett. 6 (2004) 2063-2066
151. Larsen C.H., Ridgway B.H., Shaw J.T., Smith D.M., and Woerpel K.A. J. Am. Chem. Soc. 127 (2005) 10879-10884 and the references cited therein
152. For selected examples in N-acyliminium series, see:
153. Renaud P., and Seebach D. Helv. Chim. Acta 69 (1986) 1704-1710
154. Yoda H., Yamazaki H., and Takabe K. Tetrahedron: Asymmetry 6 (1995) 2669-2672
155. Boto A., Hernández R., and Suárez E. J. Org. Chem. 65 (2000) 4930-4937
156. Brenneman J.B., and Martin S.F. Org. Lett. 6 (2004) 1329-1331
157. Oba M., Koguchi S., Nishiyama K., Kaneno D., and Tomoda S. Angew. Chem., Int. Ed. 43 (2004) 2412-2415
158. Meza-León R.L., Crich D., Bernès S., and Quintero L. J. Org. Chem. 69 (2004) 3976-3978
159. Ceccon J., Poisson J.-F., and Greene A.E. Synlett (2005) 1413-1416
160. For other approaches to DHP, see:
161. Arakawa Y., and Yoshifuji S. Chem. Pharm. Bull. 39 (1991) 2219-2224
162. Taylor C.M., Barker W.D., Weir C.A., and Park J.H. J. Org. Chem. 67 (2002) 4466-4474 and the references cited therein
163. We thank Professor Y. F. Zhao (Xiamen University) for the use of her Bruker Dalton Esquire 3000 plus LC-MS apparatus.